Concepts (51)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Diseases, Interstitial | 2 | 2025 | 292 | 1.300 |
Why?
|
| Scleroderma, Systemic | 1 | 2025 | 59 | 0.870 |
Why?
|
| Adiposity | 1 | 2023 | 76 | 0.780 |
Why?
|
| Immunosuppressive Agents | 1 | 2025 | 990 | 0.630 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2025 | 624 | 0.620 |
Why?
|
| Malaria, Falciparum | 3 | 2024 | 15 | 0.420 |
Why?
|
| Malaria Vaccines | 2 | 2024 | 5 | 0.350 |
Why?
|
| Plasmodium falciparum | 2 | 2024 | 55 | 0.240 |
Why?
|
| Mycophenolic Acid | 1 | 2025 | 85 | 0.220 |
Why?
|
| Rituximab | 1 | 2025 | 128 | 0.220 |
Why?
|
| Cyclophosphamide | 1 | 2025 | 278 | 0.210 |
Why?
|
| Sporozoites | 1 | 2024 | 3 | 0.210 |
Why?
|
| Vaccines, Attenuated | 1 | 2024 | 52 | 0.210 |
Why?
|
| Indoles | 1 | 2025 | 303 | 0.200 |
Why?
|
| Drug Therapy, Combination | 1 | 2025 | 759 | 0.190 |
Why?
|
| Adipocytes | 1 | 2023 | 169 | 0.180 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 19 | 0.180 |
Why?
|
| Rural Population | 1 | 2021 | 170 | 0.160 |
Why?
|
| Immunity, Innate | 1 | 2024 | 463 | 0.160 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2025 | 1001 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 1 | 2025 | 1053 | 0.140 |
Why?
|
| Antigens, Protozoan | 1 | 2017 | 22 | 0.130 |
Why?
|
| Inflammation | 1 | 2023 | 1050 | 0.130 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 2802 | 0.130 |
Why?
|
| Obesity | 1 | 2023 | 1018 | 0.120 |
Why?
|
| Antibodies, Protozoan | 2 | 2024 | 46 | 0.090 |
Why?
|
| Protozoan Proteins | 2 | 2024 | 73 | 0.080 |
Why?
|
| Humans | 5 | 2025 | 93515 | 0.070 |
Why?
|
| Infant | 2 | 2024 | 3220 | 0.060 |
Why?
|
| Parasitemia | 1 | 2024 | 7 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2024 | 464 | 0.050 |
Why?
|
| Kenya | 1 | 2021 | 9 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 660 | 0.040 |
Why?
|
| Prevalence | 1 | 2021 | 1321 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2017 | 239 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1847 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2017 | 696 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 3829 | 0.030 |
Why?
|
| Cell Line | 1 | 2017 | 2464 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 7061 | 0.020 |
Why?
|
| Child | 1 | 2021 | 7355 | 0.020 |
Why?
|
| Mice | 1 | 2024 | 12269 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 6930 | 0.020 |
Why?
|
| Female | 2 | 2024 | 48702 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 4560 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 9606 | 0.020 |
Why?
|
| Animals | 1 | 2024 | 28155 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 20434 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 27573 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 27918 | 0.010 |
Why?
|
| Male | 1 | 2021 | 44557 | 0.010 |
Why?
|